# OnCo record paper-c-post-adjuvant-cemiplimab-nejm-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-c-post-adjuvant-cemiplimab-nejm-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-c-post-adjuvant-cemiplimab-nejm-2025" ;
  schema:name "C-POST: adjuvant cemiplimab versus placebo in high-risk cutaneous squamous cell carcinoma"@en ;
  schema:description "A year of cemiplimab after surgery and radiotherapy for high-risk cutaneous squamous cell carcinoma cut the risk of recurrence or death by more than two thirds, the first adjuvant therapy to work in this skin cancer."@en ;
  schema:url <https://onco.cc/key-papers/paper-c-post-adjuvant-cemiplimab-nejm-2025/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2502449>, <https://pubmed.ncbi.nlm.nih.gov/40454639/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa2502449> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Rischin D, Porceddu S, Day F, et al." ;
  onco:cancers <https://onco.cc/cancers/advanced-cutaneous-scc/> ;
  onco:drugs <https://onco.cc/drugs/cemiplimab/> ;
  onco:journals <https://onco.cc/journals/nejm/> .